期刊
NATURE REVIEWS NEUROSCIENCE
卷 18, 期 12, 页码 753-769出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrn.2017.136
关键词
-
资金
- MRC [G0601744, G0802545] Funding Source: UKRI
- Medical Research Council [G0601744, G0802545, MC_PC_12009] Funding Source: Medline
- Medical Research Council [G0700711B, G0601744, MC_PC_12009, G0802545] Funding Source: researchfish
- Wellcome Trust [104783/Z/14/Z] Funding Source: researchfish
- Wellcome Trust [104783/Z/14/Z] Funding Source: Wellcome Trust
Although the core concept of remyelination - based on the activation, migration, proliferation and differentiation of CNS progenitors - has not changed over the past 20 years, our understanding of the detailed mechanisms that underlie this process has developed considerably. We can now decorate the central events of remyelination with a host of pathways, molecules, mediators and cells, revealing a complex and precisely orchestrated process. These advances have led to recent drug-based and cell-based clinical trials for myelin diseases and have opened up hitherto unrecognized opportunities for drug-based approaches to therapeutically enhance remyelination.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据